Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DRRX:US

2.7900 USD 0.1900 7.31%

As of 16:30:00 ET on 06/02/2015.

Company Profile for Durect Corp (DRRX)

Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.

Contact Information

Durect Corp

2 Results Way
Cupertino, CA 95014
United States
Phone: 1-408-777-1417
Fax: 1-408-777-3577

Key Executives for Durect Corp (DRRX)

Felix TheeuwesChairman/Chief Scientific OfcrJames E BrownPresident/CEO/Co-Founder
Matthew J HoganCFO/SecretaryJudy R JoiceSenior VP:Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil